Search Results (236)

Benzene-1,2,4-triyl tris(2-(3-carboxy-4-hydroxybenzenesulfonate) acetate) synthesis is an important step forward in the synthesis of multifunctional organic molecules, which have potential uses in material science and medical chemistry, among other domains. In analytical chemistry, it can also be utilized for metal ion determination. This work presents a thorough and methodical approach to the synthesis of this complicated trisulfonated aromatic ester, emphasizing the effectiveness and scaling possibilities of the methodology. Choosing the right precursors to ensure that each one would contribute to the intended molecular architecture was the first step in the synthesis process. In the initial stages of the synthesis process, oxyhydroquinone was reacted with chloroacetyl chloride for 20 h. As a result, benzene-1,2,4-triyl tris(2-chloroacetate) of triatomic phenol-oxyhydroquinone was formed. The resulting phenacetyl chloride was reacted with sodium sulfosalicylate in the presence of N,N-dimethylformamide (DMFA). Benzene-1,2,4-triyl tris(2-(3-carboxy-4-hydroxybenzenesulfonate) acetate) was formed. To obtain high yields and purity, careful adjustment of the reaction conditions that including temperature, solvent selection, and reagent ratios was required. The synthesized molecule was characterized using advanced spectroscopic techniques such as NMR, IR, and UV spectrometry, which confirmed its structural integrity and functional group configuration. Benzene-1,2,4-triyl tris(2-(3-carboxy-4-hydroxybenzenesulfonate) acetate), the resultant product, has special physicochemical characteristics. In particular, it is more soluble and has the potential to be a useful intermediate in organic synthesis. Because it has several reactive sites, preliminary research indicates that it may be useful in the development of new polymeric materials and as a possible ligand in coordination chemistry. Full article

Neurodegenerative diseases, including Alzheimer’s disease, are marked by cholinergic dysfunction, oxidative stress, and reduced neurotrophic support, which drives the quest for multifunctional therapeutic agents. This pilot study presents four novel monoterpene–aminoadamantane conjugates (MACs 1–4) designed to combine the antioxidant and neuromodulatory characteristics of monoterpenes with the neuroprotective properties of aminoadamantane derivatives. Their physicochemical characteristics, blood–brain barrier permeability, and binding affinity to human acetylcholinesterase (AChE) were evaluated using molecular docking and in silico descriptor analysis. In vivo, the neuroprotective efficacy of the MACs was investigated in a scopolamine-induced dementia model in rats, employing behavioral tests. Biochemical assays conducted in the hippocampus and prefrontal cortex assessed AChE activity, antioxidant enzyme performance, lipid peroxidation levels, total glutathione content, and BDNF concentrations. The findings indicate that MAC1, MAC3, and MAC4 demonstrate favorable calculated blood–brain barrier permeability, strong predicted affinity for AChE, and significant in vivo alleviation of scopolamine-induced memory deficits, in conjunction with improvement of key markers of oxidative stress and cholinergic function. These results show that the structural hybridization of myrtenal with aminoadamantane frameworks produces promising multifunctional ligands that are relevant for Alzheimer’s-type neurodegeneration. Full article

Background: The signal peptide-CUB-EGF-like domain-containing protein 3 (SCUBE3) is a secretory protein that plays a role in cancer, cardiovascular, and immune disorders. SCUBE1, SCUBE2, and SCUBE3 belong to the SCUBE family. They contain multiple copies of EGF-like repeats at the amino acid terminal, a spacer region, three cysteine-rich motifs, and a CUB domain at the carboxyl terminus. The SCUBE family members are multifunctional proteins that act primarily as extracellular ligands or co-receptors in various cells. Methods: In this study, we examined the expression pattern and role of SCUBE3 in various cancers, as well as other diseases such as cardiovascular disease and immune disorders, and its impact on growth and development. Results: SCUBE3 expression is upregulated and secreted by the cells of lung cancer, hepatocellular carcinoma (HCC), melanoma, osteosarcoma, ovarian cancer, glioma, and breast cancer. Extracellular SCUBE3 protein often binds to TGFβRII or acts as a co-receptor for TGFβ and BMP2/BMP4 in regulating cellular signaling. Through the TGFβRII signaling, SCUBE3 activities promote tumor growth, metastasis, invasion, angiogenesis, and poor clinical outcomes. Conversely, in renal cell carcinoma, SCUBE3 expression suppresses growth. Altered SCUBE3 activity is associated with cardiovascular diseases, immune disorders, and hair growth. Conclusions: The review presents mechanistic evidence that SCUBE3 plays a crucial regulatory role in multiple cancers and other diseases. The evidence suggests the SCUBE3 protein could serve as a potential molecular target for various diseases and highlights its usefulness as a minimally invasive diagnostic marker, as it is a secreted protein. Full article

The development of nanoscale chiral materials with enhanced optical properties holds significant promise for advancing technologies in light-emitting devices and enantioselective sensing. Here, we report the self-assembly of chiral metal–organic cages from an axially chiral, AIE-active binaphthyl dicarboxylate ligand. This supramolecular architecture functions as a multifunctional platform, demonstrating a high affinity for anionic guests through synergistic electrostatic and hydrogen-bonding interactions. The rigid cage framework not only enhances the ligand’s intrinsic aggregation-induced emission (AIE) but also serves as a highly effective chiral amplifier. Notably, MOCs significantly boost the circularly polarized luminescence (CPL), achieving a luminescence dissymmetry factor (|g_lum|) of 1.2 × 10⁻³. This value represents an approximately five-fold enhancement over that of the unassembled ligand. The photophysical properties of this chiral supramolecular system provide a strategic blueprint for designing next-generation optical nanomaterials. Full article

Metal–organic framework (MOF)-based surface-enhanced Raman scattering (SERS) sensors have emerged as a versatile platform for high-sensitivity and selective detection in agricultural, environmental, and biomedical applications. By integrating plasmonic nanostructures with tunable MOF architectures, these hybrid systems combine ultrahigh signal enhancement with molecular recognition, analyte preconcentration, and controlled hotspot distribution. This review provides a comprehensive overview of the fundamental principles underpinning MOF–SERS performance, including EM and chemical enhancement mechanisms, and highlights strategies for substrate design, such as metal–MOF composites, plasmon-free frameworks, ligand functionalization, and hierarchical or core–shell architectures. We further examine their applications in environmental monitoring, pesticide and contaminant detection, pathogen identification, biomarker analysis, and theranostics, emphasizing real-sample performance, molecular selectivity, and emerging integration with portable Raman devices and AI-assisted data analysis. Despite notable advances, challenges remain in reproducibility, quantitative reliability, matrix interference, scalability, and biocompatibility. Future developments are likely to focus on rational MOF design, sustainable fabrication, intelligent spectral interpretation, and multifunctional integration to enable robust, field-deployable sensors. Overall, MOF-based SERS platforms represent a promising next-generation analytical tool poised to bridge laboratory innovation and practical, real-world applications. Full article

The urgent need for effective therapies against cancer and antimicrobial-resistant pathogens motivates the development of novel metal-based complexes. Herein, we report the synthesis and characterization of four novel cobalt(II) complexes with biologically relevant β-diketo ester ligands. The complexes were characterized via UV-Vis, FTIR, mass spectrometry, and elemental analysis. Their biological activities were evaluated through antimicrobial and cytotoxic assays. Complex B1 exhibited the strongest antimicrobial activity, with minimum inhibitory concentrations (MICs) of 0.23 mg/mL against Staphylococcus aureus and Proteus mirabilis, and 0.01 mg/mL against Mucor mucedo, exceeding the performance of ketoconazole. Cytotoxicity studies on SW480 colorectal cancer cells and HaCaT normal keratinocytes identified B3 as the most potent anticancer agent (IC₅₀ = 11.49 µM), selectively targeting tumor cells. Morphological analysis indicated apoptosis as the primary mode of cell death. Mechanistic studies were performed to elucidate interactions with biomolecules. UV-Vis and fluorescence spectroscopy, viscosity measurements, and molecular docking revealed that B3 binds strongly to calf thymus DNA via hydrophobic interactions and groove binding, and exhibits selective binding to bovine serum albumin (site II, subdomain IIIA). These results highlight the potential of cobalt(II) complexes as multifunctional agents with significant antimicrobial and antitumor activities and provide detailed insight into their molecular interactions with DNA and serum proteins. Full article

Pharmaceutical residues are increasingly emerging in global drinking water sources, posing serious ecological and public health challenges by altering the physicochemical balance of aquatic systems. Among available purification approaches, adsorption remains one of the most promising techniques due to its simplicity, cost-effectiveness, and efficiency. In this work, a ternary nanocomposite of Cu- and ZnO-decorated carboxylated graphene oxide (Cu/ZnO@CGO) was synthesized and utilized for highly efficient and ultrafast removal of the antidiabetic drug metformin from aqueous environments. The adsorption mechanism arises from a synergistic combination of surface complexation on Cu nanoparticles, cation–π and π–π electron donor–acceptor interactions with the CGO aromatic structure, and hydrogen bonding through the amino groups of metformin and the oxygen-rich functional moieties of ZnO and CGO. The nanocomposite was thoroughly characterized using FTIR, XPS, XRD, SEM, HRTEM, and TGA analyses, confirming its well-defined hybrid structure. Unlike conventional single-phase or binary systems, the Cu/ZnO@CGO nanocomposite demonstrated remarkable cooperative effects that enhanced its performance through the integration of metal–ligand coordination, π–π stacking, cation–π forces, and hydrogen bonding. These interactions contributed to an outstanding adsorption capacity of 232.56 mg·g⁻¹ and an exceptionally fast equilibrium time of only 25 min. Moreover, the material maintained excellent reusability, with merely a 4.1% decline in efficiency after five regeneration cycles, and achieved almost complete removal of metformin (99.7 ± 3.4%) from several real water samples, namely river, tap, and bottled water. The unique structural design of Cu/ZnO@CGO prevents CGO aggregation and facilitates efficient contaminant capture even at trace concentrations, establishing it as a highly competitive and sustainable adsorbent for pharmaceutical wastewater treatment. Overall, this study highlights a novel and rationally engineered nanocomposite whose synergistic surface chemistry bridges adsorption and detoxification, providing valuable insight into the next generation of multifunctional graphene-based materials for environmental remediation. Full article

This study presents the development and evaluation of multifunctional, thermoresponsive nanogels based on poly(N-vinylcaprolactam-co-N-vinylpyrrolidone) (P(NVCL-co-NVP)) with a poly(ethylene glycol) methyl ether methacrylate (PEGMA) shell and galactose (GAL) targeting ligand for colon cancer therapy. The nanogels were engineered to encapsulate two chemotherapeutic agents, curcumin (CUR) and 5-fluorouracil (5-FU), along with gold nanorods (GNRDs) to enable a synergistic chemo-photothermal treatment approach. These nanogels exhibit excellent biocompatibility and stability and a temperature-responsive drug release profile, leveraging the volume-phase transition temperature (VPTT) of the polymer network for controlled delivery. The inclusion of GNRDs permits efficient photothermal conversion upon near-infrared (NIR) irradiation, resulting in localized hyperthermia and, theoretically, improved cytotoxicity when combined with chemotherapeutics. In vitro studies on colon cancer cells demonstrated enhanced drug accumulation, photothermal ablation when the GNRD concentration was above a threshold, and superior antitumor efficacy of the CUR/5-FU-loaded systems. The effectiveness of the chemo/photothermal combination could not be demonstrated, possibly due to the low concentration of GNRD and/or the use of a single irradiation step only. This work highlights the potential of P(NVCL-co-NVP):PEGMA:GAL nanogels as versatile nanocarriers for combined chemo-photothermal therapy. A more effective chemo/photothermal combination for colon cancer treatment can be achieved through the optimization of the GNRD loading/irradiation dosage. Full article

Therapeutic peptides have rapidly evolved into multifunctional tools for precision oncology, offering molecular specificity and biocompatibility. Their roles in cancer therapy, however, are inherently overlapping. The same peptide can function as a targeting ligand, a cell-penetrating motif, a therapeutic effector, or a structural component of peptide–drug conjugates (PDCs), nanoparticle (NP) systems, and radionuclide constructs. This functional convergence makes rigid classification challenging. In this review, we therefore organize peptide modalities according to their dominant therapeutic function while acknowledging the fluid boundaries between categories. Firstly, we outline the main functional classes of therapeutic peptides, covering their use as targeting ligands and their roles as active agents (i.e., receptor agonists/antagonists, intracellular protein–protein interaction modulators, etc.). Additionally, we summarize their application in peptide–drug conjugates (PDCs), peptide-guided radionuclides, and cancer vaccines, integrating key mechanistic principles and clinical evidence. Finally, we discuss the major translational barriers to clinical use and how they might be overcome. The developments in peptide engineering position them as adaptable, multifunctional platforms capable of improving precision, reducing toxicity, and advancing personalized cancer care. Full article

The rhenium(I) tricarbonyl complex fac-[Re(CO)₃(5,6-epoxy-5,6-dihydro-1,10-phenanthroline)Br] (ReL) has previously demonstrated promising luminescent properties, enabling its direct application as a probe for walled cells such as Candida albicans and Salmonella enterica. In this new study, we present a significantly expanded and comprehensive characterization of ReL, incorporating a wide range of experimental and computational techniques not previously reported. These include variable-temperature ¹H and ¹³C NMR spectroscopy, CH-COSY, single-crystal X-ray diffraction, Hirshfeld surface analysis, DFT calculations, Fukui functions, non-covalent interaction (NCI) indices, and electrochemical profiling. Structural analysis confirmed a pseudo-octahedral geometry with the bromide ligand positioned cis to the epoxy group. NMR data revealed the coexistence of cis and trans isomers in solution, with the trans form being slightly more stable. DFT calculations and aromaticity descriptors indicated minimal electronic differences between isomers, supporting their unified treatment in subsequent analyses. Electrochemical studies revealed two oxidation and two reduction events, consistent with ECE and EEC mechanisms, including a Re(I) → Re(0) transition at −1.50 V vs. SCE. Theoretical redox potentials showed strong agreement with experimental data. Biological assays revealed a dose-dependent cytotoxic effect on HeLa cells, contrasting with previously reported low toxicity in microbial systems. These findings, combined with ReL’s luminescent and antimicrobial properties, underscore its multifunctional nature and highlight its potential as a bioactive and imaging agent for advanced therapeutic and microbiological applications. Full article

Skin aging, driven by oxidative stress, UV exposure, inflammation, and extracellular matrix degradation, necessitates the discovery of safer, multi-target natural products. We established an integrated pipeline combining UHPLC–MS/MS metabolomics, computational methods (network pharmacology, molecular docking, and dynamics simulation), and in vitro bioassays to efficiently discover and mechanistically characterize anti-aging compounds from novel botanical sources. We applied this pipeline to identify and evaluate Tephroseris flammea, a previously unassessed plant. Metabolomic profiling identified 21 compounds, including flavonoids, phenylpropanoids, and pyrrolizidine alkaloids. These compounds were linked via network pharmacology to 226 skin-aging-related targets, primarily involving inflammation (via AKT1, RELA) and matrix degradation (via MAPK3). Molecular docking and 100 ns molecular dynamics simulations confirmed stable ligand-target interactions with favorable binding energies. Validating these in silico predictions, the T. flammea extract demonstrated significant antioxidant activity and effectively suppressed key inflammatory mediators (IL-6, TNF-α, COX-2) and MMP-1 levels in UVB-exposed fibroblasts, notably without significant cytotoxicity. Collectively, this study validates the utility of our pipeline to mechanistically characterize complex botanicals, revealing that T. flammea contains multifunctional compounds modulating critical inflammatory and matrix-regulatory cascades. This work validates our pipeline for identifying novel, mechanistically defined ingredients from complex botanical sources. Full article

Tribolium castaneum, the red flour beetle, is both a major pest of stored products and a valuable genetic model. Odorant Binding Proteins (OBPs), traditionally associated with olfaction, are now recognized as multifunctional, contributing to detoxification, immunity, and reproduction. This review synthesizes recent advances in the molecular structure, gene expression, and functional characterization of T. castaneum OBPs—particularly TcOBPC11, TcOBPC12, TcOBPC17, and TcOBP7G. Experimental evidence, including RNA interference, ligand-binding assays, and expression profiling, supports their role in defense against xenobiotics. Comparative genomic analyses reveal lineage-specific expansions and adaptive evolution, especially in Minus-C OBPs. Translational applications include RNA interference (RNAi)-based pest control, OBP-targeting repellents, and biosensors. Outstanding challenges remain, including structural resolution and functional redundancy. Future research integrating CRISPR, single-cell transcriptomics, and structural biology will be critical to decode OBP regulatory networks and leverage their potential in pest management and biotechnology. Full article

Oxidative stress, UV exposure, inflammation, and extracellular matrix degradation collectively drive skin aging, underscoring the need for safe, multi-target therapeutic options. We developed and applied an integrated analytical pipeline combining UHPLC–MS/MS metabolomics, computational analyses (network pharmacology, molecular docking, and molecular dynamics simulation), and experimental bioassays to efficiently identify and characterize novel natural products with anti-aging potential. This workflow was applied to Melampyrum roseum Maxim., a previously unassessed hemiparasitic plant of the Orobanchaceae family, to elucidate its bioactive potential against skin aging. UHPLC–MS/MS profiling annotated 13 secondary metabolites, predominantly flavone aglycones, iridoid glycosides, and phenylpropanoid derivatives. Network pharmacology analysis linked these metabolites to 172 potential skin-aging-associated targets, mainly within inflammatory, ECM, and oxidative-stress pathways. Molecular docking and 100-ns molecular dynamics simulations confirmed stable ligand-target interactions with favorable binding energies, particularly with AKT1, EGFR, PTGS2 and XDH. Validating these predictions, the M. roseum extract demonstrated significant antioxidant activity and effectively suppressed key inflammatory mediators (IL-6, TNF-α, COX-2) and MMP-1 levels in UVB-exposed fibroblasts, notably without significant cytotoxicity. Collectively, these findings demonstrate that M. roseum harbors multifunctional metabolites that modulate key inflammatory and matrix-regulatory pathways, providing preliminary mechanistic evidence for its potential as a promising candidate for natural anti-aging applications. Full article

Glioblastoma multiforme (GBM) is a highly aggressive primary brain tumour with limited treatment options and a poor prognosis. Therapeutic failure is driven by multiple barriers, including the blood–brain barrier (BBB), the tumour microenvironment (TME), and intratumoural heterogeneity. Conventional delivery systems often fail to achieve sufficient drug accumulation or controlled release within the tumour. In this review, we outline a theoretical framework for the design of ligand-functionalised magnetic lipid nanoparticles (MF-R-LNs), a multifunctional nanoplatform that integrates active targeting, stimuli-responsive drug release, and external magnetic-field control. The proposed MF-R-LNs incorporate superparamagnetic iron oxide nanoparticles (SPIONs) for magnetic guidance and hyperthermia; polyethylene glycol (PEG) for extended circulation; and surface ligands such as peptides, antibodies, or aptamers to target GBM-specific receptors including epidermal growth factor receptor (EGFR), Interleukin-13 receptor alpha-2 (IL-13Rα2), and integrins. Triggered release mechanisms such as pH-sensitive lipids, redox cleavable linkers, and enzyme-responsive coatings enable selective drug release within the TME. Magnetic hyperthermia serves as both a therapeutic modality and a remote trigger to enhance release and tumour penetration. This modular design offers a theoretically robust strategy to overcome the key physiological and therapeutic barriers in GBM. We discuss the rationale behind each design feature, explore potential synergies, and highlight translational challenges such as tumour heterogeneity, manufacturing complexity, and safety concerns. Despite encouraging preclinical evidence, clinical translation faces substantial hurdles, notably patient-specific heterogeneity and scalable GMP manufacturing/characterisation of multi-component nanoplatforms. While preclinical validation remains necessary, this framework may inform future efforts to develop spatiotemporally controlled, multifunctional therapeutics for glioblastoma. This manuscript is a conceptual framework review that synthesises current strategies into actionable guidance for designing and reporting MF-R-LNs for GBM. Full article

Lipid-polymer hybrid nanoparticles (LPHNPs) are the next-generation nanocarriers that integrate the mechanical strength and sustained-release capacity of polymeric cores with the biocompatibility and high drug-loading efficiency of lipid shells. Various design strategies and architectures that enhance encapsulation efficiency, stability, and targeted delivery of diverse therapeutic agents are reviewed. Commonly employed polymers, lipids, and surfactants that enable controlled drug release and enhanced pharmacokinetic performance are summarized in tabular form, while fabrication methods such as single-step, emulsification-solvent evaporation, and microfluidic techniques are discussed for their scalability and reproducibility. The therapeutic potential of LPHNPs in delivering poorly soluble drugs, phytochemicals, and genetic materials achieving synergistic therapeutic outcomes in oncological applications is comprehensively highlighted. The manuscript also includes details on ligand-based functionalization and the integration of imaging and stimuli-responsive elements to enhance targeted delivery and develop multifunctional theranostic LPHNPs systems. Furthermore, non-oncologic applications of LPHNPs in ocular, topical, and oral delivery are discussed, emphasizing their potential in treating inflammatory, infectious, and autoimmune disorders with sustained release and enhanced therapeutic efficacy. Recent patents focusing on improved biocompatibility, dual-drug encapsulation, and mRNA delivery are summarized. However, challenges such as large-scale production, reproducibility, safety, and regulatory standardization must be addressed through quality by design approaches and advanced manufacturing technologies to fully realize the clinical and commercial potential of next-generation LPHNPs. Full article